• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过拷贝数变异阵列检测到的 和 的缺失与胸膜间皮瘤中p16和MTAP蛋白的缺失相关。

Deletions of and Detected by Copy-Number Variation Array Are Associated with Loss of p16 and MTAP Protein in Pleural Mesothelioma.

作者信息

Vrugt Bart, Kirschner Michaela B, Meerang Mayura, Oehl Kathrin, Wagner Ulrich, Soltermann Alex, Moch Holger, Opitz Isabelle, Wild Peter J

机构信息

Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.

Department of Thoracic Surgery, University Hospital Zurich, 8091 Zurich, Switzerland.

出版信息

Cancers (Basel). 2023 Oct 13;15(20):4978. doi: 10.3390/cancers15204978.

DOI:10.3390/cancers15204978
PMID:37894345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10605896/
Abstract

deletion is a common alteration in pleural mesothelioma (PM) and frequently associated with co-deletion of . Since the standard detection method for deletion and FISH analysis is relatively expensive, we here investigated the suitability of inexpensive p16 and MTAP IHC by comparing concordance between IHC and OncoScan CNV arrays on samples from 52 PM patients. Concordance was determined using Cohen's kappa statistics. Loss of was associated with co-deletion of in 71% of cases. copy-number normal cases were also IHC positive in 93% of cases for p16 and 100% for MTAP, while homozygous deletion of was always associated with negative IHC for both proteins. In cases with heterozygous loss, IHC expression of p16 and MTAP was negative in 100% and 71%, respectively. MTAP and p16 IHC showed high sensitivity (MTAP 86.5%, p16 100%) and specificity (MTAP 100%, p16 93.3%) for the detection of any gene loss. Loss of MTAP expression occurred exclusively in conjunction with loss of p16 labeling. Both p16 and MTAP IHC showed high concordance with Oncoscan CNV arrays (kappa = 0.952, < 0.0001, and kappa = 0.787, < 0.0001 respectively). We recommend combined MTAP and p16 immunohistochemistry to confirm the diagnosis of PM.

摘要

缺失是胸膜间皮瘤(PM)中常见的改变,且常与……的共同缺失相关。由于用于……缺失检测的标准方法和荧光原位杂交(FISH)分析相对昂贵,我们在此通过比较52例PM患者样本的免疫组化(IHC)与OncoScan拷贝数变异(CNV)阵列之间的一致性,研究了廉价的p16和MTAP免疫组化的适用性。使用科恩kappa统计量确定一致性。在71%的病例中,……的缺失与……的共同缺失相关。……拷贝数正常的病例中,93%的p16病例和100%的MTAP病例免疫组化也呈阳性,而……的纯合缺失总是与这两种蛋白的免疫组化阴性相关。在杂合性……缺失的病例中,p16和MTAP的免疫组化表达分别在100%和71%的病例中为阴性。MTAP和p16免疫组化在检测任何基因缺失方面显示出高灵敏度(MTAP为86.5%,p16为100%)和特异性(MTAP为100%,p16为93.3%)。MTAP表达的缺失仅与p16标记的缺失同时出现。p16和MTAP免疫组化与Oncoscan CNV阵列均显示出高度一致性(kappa分别为0.952,P<0.0001和kappa为0.787,P<0.0001)。我们建议联合使用MTAP和p16免疫组化来确诊PM。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/10605896/a04bed0aed46/cancers-15-04978-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/10605896/6fbf003d2621/cancers-15-04978-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/10605896/7521a67c5ea0/cancers-15-04978-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/10605896/b0d1f05f4869/cancers-15-04978-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/10605896/a04bed0aed46/cancers-15-04978-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/10605896/6fbf003d2621/cancers-15-04978-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/10605896/7521a67c5ea0/cancers-15-04978-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/10605896/b0d1f05f4869/cancers-15-04978-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/10605896/a04bed0aed46/cancers-15-04978-g004.jpg

相似文献

1
Deletions of and Detected by Copy-Number Variation Array Are Associated with Loss of p16 and MTAP Protein in Pleural Mesothelioma.通过拷贝数变异阵列检测到的 和 的缺失与胸膜间皮瘤中p16和MTAP蛋白的缺失相关。
Cancers (Basel). 2023 Oct 13;15(20):4978. doi: 10.3390/cancers15204978.
2
Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry.免疫组化检测 MTAP 和 BAP1 蛋白缺失在间皮瘤诊断中的应用:与 9p21 FISH 和 BAP1 免疫组化的比较。
Lung Cancer. 2017 Feb;104:98-105. doi: 10.1016/j.lungcan.2016.12.017. Epub 2016 Dec 23.
3
Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma.胸腔细胞学标本中 MTAP 和 BAP1 染色丢失及 P16/CDKN2A 缺失的研究及其在间皮瘤诊断中的作用。
Diagn Cytopathol. 2024 Apr;52(4):211-216. doi: 10.1002/dc.25272. Epub 2024 Jan 20.
4
Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features.在诊断具有间皮瘤特征的促纤维增生性间皮瘤/肉瘤样胸膜间皮瘤时,MTAP 免疫组化的挑战和局限性。
Ann Diagn Pathol. 2022 Oct;60:152004. doi: 10.1016/j.anndiagpath.2022.152004. Epub 2022 Jun 30.
5
A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas.MTAP与p16免疫组织化学联合应用可替代CDKN2A荧光原位杂交用于胸膜间皮瘤的诊断和预后评估。
Arch Pathol Lab Med. 2023 Mar 1;147(3):313-322. doi: 10.5858/arpa.2021-0331-OA.
6
Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma.比较免疫组织化学、下一代测序和荧光原位杂交在胸膜间皮瘤中检测 MTAP 缺失的应用。
Mod Pathol. 2024 Mar;37(3):100420. doi: 10.1016/j.modpat.2023.100420. Epub 2024 Jan 5.
7
Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.MTAP与p16/CDKN2A表达在胃食管癌发生过程中的一致性缺失:食管非侵袭性前驱病变中纯合缺失的证据及治疗意义
Am J Surg Pathol. 2005 Nov;29(11):1497-504. doi: 10.1097/01.pas.0000170349.47680.e8.
8
CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival.CDKN2A 和 MTAP 缺失与腹膜间皮瘤中 p16 蛋白表达缺失和不良预后相关。
Mod Pathol. 2010 Apr;23(4):531-8. doi: 10.1038/modpathol.2009.186. Epub 2010 Jan 15.
9
Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series.氟代硅酸钙诱发胸膜间皮瘤中 CDKN2A 纯合缺失与 MTAP 免疫组化缺失的一致性:单机构系列的免疫组化和分子研究。
Pathol Res Pract. 2024 Jul;259:155350. doi: 10.1016/j.prp.2024.155350. Epub 2024 May 14.
10
Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma.恶性胸膜间皮瘤中甲基硫代腺苷磷酸化酶(MTAP)蛋白表达与 MTAP 和 CDKN2A 拷贝数的相关性。
Histopathology. 2021 Jun;78(7):1032-1042. doi: 10.1111/his.14324. Epub 2021 Apr 14.

引用本文的文献

1
Challenging CDKN2A assessment in BRAF-altered gliomas: lessons from a pleomorphic xanthoastrocytoma-enriched cohort.BRAF 基因改变的胶质瘤中 CDKN2A 评估面临的挑战:来自富含多形性黄色星形细胞瘤队列的经验教训
Acta Neuropathol Commun. 2025 Aug 11;13(1):170. doi: 10.1186/s40478-025-02089-7.
2
MTAP immunohistochemistry as a surrogate marker of CDKN2A loss in brain tumors: A meta-analysis and literature review.MTAP免疫组化作为脑肿瘤中CDKN2A缺失的替代标志物:一项荟萃分析与文献综述
J Neuropathol Exp Neurol. 2025 Apr 18. doi: 10.1093/jnen/nlaf033.
3
Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets.

本文引用的文献

1
A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas.MTAP与p16免疫组织化学联合应用可替代CDKN2A荧光原位杂交用于胸膜间皮瘤的诊断和预后评估。
Arch Pathol Lab Med. 2023 Mar 1;147(3):313-322. doi: 10.5858/arpa.2021-0331-OA.
2
The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification.《2021年世界卫生组织胸膜肿瘤分类:自2015年分类以来的进展》
J Thorac Oncol. 2022 May;17(5):608-622. doi: 10.1016/j.jtho.2021.12.014. Epub 2022 Jan 10.
3
Alterations in Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma.
恶性胸膜间皮瘤:从病理生理学到创新的可操作靶点
Cancers (Basel). 2025 Mar 30;17(7):1160. doi: 10.3390/cancers17071160.
4
Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma.胸膜间皮瘤病理诊断方法中的挑战
Cancers (Basel). 2025 Feb 1;17(3):481. doi: 10.3390/cancers17030481.
5
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial.MAT2A抑制剂AG-270/S095033用于晚期恶性肿瘤患者:一项I期试验
Nat Commun. 2025 Jan 6;16(1):423. doi: 10.1038/s41467-024-55316-5.
6
Immunotherapy for Treatment of Pleural Mesothelioma: Current and Emerging Therapeutic Strategies.胸膜间皮瘤的免疫治疗:当前和新兴的治疗策略。
Int J Mol Sci. 2024 Oct 9;25(19):10861. doi: 10.3390/ijms251910861.
7
BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report.意大利间皮瘤诊断中BAP1缺失、核分级及非上皮样特征:若无病理报告,绝不再如此。
J Pers Med. 2024 Apr 8;14(4):394. doi: 10.3390/jpm14040394.
这些改变与顺铂耐药性有关,通过抑制恶性胸膜间皮瘤细胞凋亡。
Clin Cancer Res. 2021 Apr 15;27(8):2277-2291. doi: 10.1158/1078-0432.CCR-20-4037. Epub 2021 Feb 5.
4
Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma.恶性胸膜间皮瘤中甲基硫代腺苷磷酸化酶(MTAP)蛋白表达与 MTAP 和 CDKN2A 拷贝数的相关性。
Histopathology. 2021 Jun;78(7):1032-1042. doi: 10.1111/his.14324. Epub 2021 Apr 14.
5
MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma.MTAP 免疫组化是一种准确且可重复的 CDKN2A 荧光原位杂交替代方法,可用于恶性胸膜间皮瘤的诊断。
Mod Pathol. 2020 Feb;33(2):245-254. doi: 10.1038/s41379-019-0310-0. Epub 2019 Jun 23.
6
Role of p16 deletion and BAP1 loss in the diagnosis of malignant mesothelioma.p16缺失和BAP1缺失在恶性间皮瘤诊断中的作用。
J Thorac Dis. 2018 Sep;10(9):5522-5530. doi: 10.21037/jtd.2018.08.59.
7
Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes.第十四届国际间皮瘤兴趣小组会议要点:良性和恶性间皮瘤增生的病理分离以及恶性间皮瘤亚型的组织学/分子分析。
Lung Cancer. 2018 Oct;124:95-101. doi: 10.1016/j.lungcan.2018.07.041. Epub 2018 Jul 30.
8
Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas.甲基硫腺苷磷酸化酶与 BAP1 免疫组化、CDKN2A 和 NF2 荧光原位杂交在区分反应性间皮增生与上皮样恶性间皮瘤中的应用。
Arch Pathol Lab Med. 2018 Dec;142(12):1549-1553. doi: 10.5858/arpa.2018-0273-OA. Epub 2018 Jul 30.
9
Heterogeneity in Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的异质性。
Int J Mol Sci. 2018 May 30;19(6):1603. doi: 10.3390/ijms19061603.
10
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.恶性间皮瘤病理诊断指南:国际间皮瘤兴趣小组共识声明2017年更新版
Arch Pathol Lab Med. 2018 Jan;142(1):89-108. doi: 10.5858/arpa.2017-0124-RA. Epub 2017 Jul 7.